LGALS3 and papillary carcinoma: The expression was more common in Papillary carcinoma as compared to follicular carcinoma because out of 28 PC, 21(75%) showed positive reaction and only 7 (25%) showed negative reaction while out of 9 follicular carcinoma only 3 (33%) showed positive staining for Galectin-3 antibody while 6 (67%) remained negative.